➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
McKesson
McKinsey
Johnson and Johnson

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for PSN-632,408


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug PSN-632,408?

PSN-632,408 is an investigational drug.

There have been 6 clinical trials for PSN-632,408. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Neurotoxicity Syndromes, and Low Back Pain. The leading clinical trial sponsors are Sanofi, Attikon Hospital, and Asklepieion Voulas General Hospital.

Recent Clinical Trials for PSN-632,408
TitleSponsorPhase
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of AlbertaN/A
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyUniversity of TorontoN/A
Ultrasound-guided Sacroiliac Joint Radiofrequency Ablation: A Pilot StudyWestern University, CanadaN/A

See all PSN-632,408 clinical trials

Clinical Trial Summary for PSN-632,408

Top disease conditions for PSN-632,408
Top clinical trial sponsors for PSN-632,408

See all PSN-632,408 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Express Scripts
Dow
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.